Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Thu, 02/22/18 - 09:12 am
Tags:
Novo Nordisk, Eli Lilly, diabetes, clinical trials, semaglutide, Trulicity
Bring on Novo Nordisk’s semaglutide, Eli Lilly says. We’re ready
Fierce Pharma
Mon, 02/12/18 - 11:00 am
Tags:
Novo Nordisk, semaglutide, Eli Lilly, Ozempic, Trulicity
Novo Nordisk’s once-weekly Type II diabetes med approved in Europe
Drug Delivery Business News
Fri, 02/9/18 - 09:30 am
Tags:
Novo Nordisk, diabetes, type 2 diabetes, Europe, Ozempic
Novo Nordisk's Dichotomy Abounds
Motley Fool
Tue, 02/6/18 - 08:45 pm
Tags:
Novo Nordisk, diabetes, earnings
Novo Nordisk launches two new diabetes drugs in U.S.
Drug Delivery Business News
Mon, 02/5/18 - 07:10 pm
Tags:
Novo Nordisk, diabetes, Ozempic, Fiasp
Shares in Novo Nordisk sink after Q4 earnings, sales disappoint
Drug Delivery Business News
Thu, 02/1/18 - 11:31 am
Tags:
Novo Nordisk, earnings
Sanofi beats Novo to buy Ablynx for 3.9 billion euros in biotech M&A boom
Yahoo/Reuters
Mon, 01/29/18 - 10:33 am
Tags:
Sanofi, Novo Nordisk, M&A, biotech, Ablynx
Novo Nordisk’s once-weekly diabetes injection cleared in Canada
Drug Delivery Business News
Wed, 01/10/18 - 10:10 am
Tags:
Novo Nordisk, diabetes, Canada, Ozempic
FDA Denies Novo Nordisk Petition on Liraglutide Generics
RAPS.org
Mon, 01/8/18 - 10:00 pm
Tags:
FDA, Novo Nordisk, liraglutide, generics, diabetes
Novo Nordisk puts $3B on the table for Ablynx
Biopharma Dive
Mon, 01/8/18 - 11:48 am
Tags:
Novo Nordisk, Ablynx, M&A
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Tags:
Gilead Sciences, Bictegravir/F/TAF, Novo Nordisk, semaglutide, Ozempic, Incyte, epacadostat, AbbVie, Rova-T, Celgene, ozanimod
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Tags:
Europe, AstraZeneca, Lynparza, ovarian cancer, Novo Nordisk, diabetes, semaglutide
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
Tags:
drug launches, Bictegravir/F/TAF, Gilead Sciences, semaglutide, Novo Nordisk, epacadostat, Incyte, Rova-T, AbbVie, ozanimod, Celgene, apalutamide, JNJ, Elagolix, AVXS-101, AveXis, lanadelumab, Shire, Epidiolex, GW Pharma
Novo gains FDA OK for semaglutide
BioPharma Dive
Wed, 12/6/17 - 11:48 pm
Tags:
Novo Nordisk, semaglutide, FDA, Ozempic, type 2 diabetes
Sanofi touts head-to-head comparison of long-acting insulin products
Drug Delivery Business News
Mon, 12/4/17 - 11:48 am
Tags:
Sanofi, insulin, diabetes, Toujeo, long-acting insulin, Novo Nordisk, Tresiba
NovoNordisk’s CSO openly addresses state of pharma sector
GoinPharma
Fri, 12/1/17 - 11:41 am
Tags:
Novo Nordisk, Victoza, NASH, PCSK9 inhibitors
Novo Nordisk targets a new treatment area through an acquisition
GoinPharma
Fri, 11/24/17 - 11:28 am
Tags:
Novo Nordisk, M&A
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Endpoints
Tue, 11/21/17 - 11:28 am
Tags:
Novo Nordisk, obesity, semaglutide
Novo Nordisk cutting 185 jobs, adding another 70 in commercial revamp
Fierce Pharma
Fri, 11/10/17 - 10:16 pm
Tags:
Novo Nordisk, layoffs
[forum discussion]RIP Novo
Cafepharma Message Boards
Thu, 11/9/17 - 11:58 am
Tags:
Novo Nordisk, layoffs, drug reps

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.